London, UK (PRWEB) May 18, 2015
Molecular diagnostics represents one of the most rapidly advancing areas of research and medicine. Detection of infectious diseases represents one of key fields where molecular diagnostics is applied. A number of important developments in this field took place over the past few years, such as development of companion diagnostics for drug development, swift expansion of molecular diagnostic test menus, multiplex testing, and more.
Abbott Laboratories, bioMérieux, BD and Roche Diagnostics are the most powerful players of the marketplace. At present, the USA is the number one in the molecular diagnostics space, while Europe and Japan are other prominent markets.
The demand for effective diagnostic tests for infectious diseases is expected to accelerate in the upcoming years, thus encouraging rapid growth of the market. Human genetic testing, pharmacogenomics and cancer testing are expected to increase their shares in the market for molecular diagnostics in the nearest future, while the infectious disease space is set to continue growing.
New market research report “Molecular Diagnostics in Infectious Disease Testing” worked out by TriMark Publications is now available at MarketPublishers.com.
Title: Molecular Diagnostics in Infectious Disease Testing
Published: May, 2015
Price: US$ 3,850.00
The research report offers an up-close look at molecular diagnostics for infectious disease testing. The study contains a detailed overview of molecular diagnostics and opportunities it has in the infectious disease sector. It discusses the marketplace in detail, scrutinizes market drivers and restraints and unveils market and technology trends. The report casts light on performance of market segments and discloses valuable data related to molecular diagnostic testing technology for infectious disease testing. The research study covers the business environment and includes information on the latest activities of market participants. It delves deep into reimbursement and billing landscape and touches upon regulatory requirements. The research report focuses on business decisions and economics of anti-microbial drug resistance. The study profiles top companies and forecast future development trends of the marketplace.
- insightful overview of the marketplace;
- valuable data on technologies and market trends;
- discussion of market segments;
- coverage of business landscape and regulatory requirements;
- company profiles;
- future market outlook;
- and more.
More new market research reports by the publisher can be found at TriMark Publications page.